Biora Therapeutics Inc
NASDAQ:BIOR
Cash Flow Statement
Cash Flow Statement
Biora Therapeutics Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(194)
|
(241)
|
(193)
|
(208)
|
(233)
|
(230)
|
(247)
|
(229)
|
(156)
|
(117)
|
(38)
|
(42)
|
(54)
|
(122)
|
(124)
|
(111)
|
(87)
|
(32)
|
|
| Depreciation & Amortization |
7
|
9
|
5
|
5
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Non-Cash Items |
36
|
39
|
73
|
57
|
54
|
60
|
104
|
113
|
76
|
58
|
(23)
|
(15)
|
(5)
|
64
|
66
|
54
|
30
|
(27)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
8
|
9
|
4
|
4
|
5
|
3
|
8
|
8
|
9
|
10
|
6
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
|
| Change in Working Capital |
22
|
14
|
(51)
|
(37)
|
(30)
|
(30)
|
(26)
|
(28)
|
(48)
|
(35)
|
(5)
|
4
|
14
|
12
|
9
|
8
|
8
|
12
|
|
| Cash from Operating Activities |
(128)
N/A
|
(180)
-40%
|
(166)
+8%
|
(183)
-11%
|
(206)
-12%
|
(197)
+4%
|
(167)
+15%
|
(143)
+15%
|
(127)
+11%
|
(93)
+26%
|
(64)
+31%
|
(53)
+18%
|
(45)
+15%
|
(46)
-3%
|
(48)
-6%
|
(49)
-1%
|
(48)
+1%
|
(46)
+5%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(5)
|
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
11
|
11
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
6
|
6
|
|
| Cash from Investing Activities |
6
N/A
|
5
-24%
|
(5)
N/A
|
(4)
+13%
|
(4)
0%
|
(3)
+24%
|
(1)
+62%
|
(1)
+10%
|
(1)
+30%
|
(1)
+35%
|
(1)
-55%
|
(0)
+42%
|
(0)
+43%
|
(0)
+62%
|
2
N/A
|
5
+123%
|
5
-3%
|
5
0%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
192
|
191
|
138
|
151
|
88
|
129
|
172
|
151
|
114
|
76
|
12
|
22
|
28
|
27
|
26
|
16
|
14
|
14
|
|
| Net Issuance of Debt |
13
|
13
|
99
|
99
|
84
|
84
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
10
|
13
|
13
|
21
|
|
| Other |
0
|
0
|
(7)
|
(9)
|
(10)
|
(18)
|
(6)
|
(4)
|
(3)
|
2
|
(5)
|
(5)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
|
| Cash from Financing Activities |
205
N/A
|
204
0%
|
230
+13%
|
241
+5%
|
163
-33%
|
195
+20%
|
165
-16%
|
146
-12%
|
110
-25%
|
76
-30%
|
7
-90%
|
16
+123%
|
23
+40%
|
21
-6%
|
31
+44%
|
24
-23%
|
22
-8%
|
31
+43%
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
83
N/A
|
29
-65%
|
59
+103%
|
54
-9%
|
(47)
N/A
|
(5)
+89%
|
(4)
+31%
|
2
N/A
|
(18)
N/A
|
(18)
+2%
|
(58)
-228%
|
(37)
+37%
|
(22)
+40%
|
(24)
-11%
|
(15)
+38%
|
(20)
-29%
|
(21)
-8%
|
(9)
+56%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(133)
N/A
|
(186)
-40%
|
(171)
+8%
|
(188)
-10%
|
(210)
-12%
|
(200)
+5%
|
(168)
+16%
|
(144)
+15%
|
(127)
+11%
|
(94)
+26%
|
(65)
+31%
|
(53)
+19%
|
(45)
+15%
|
(46)
-2%
|
(49)
-6%
|
(49)
-1%
|
(48)
+1%
|
(46)
+5%
|
|